Q100593991

Summary

Q100593991 is an implementing regulation^[1].

Key Facts

• Q100593991 is in the country of Sweden^[2].
• Q100593991's instance of is recorded as implementing regulation^[3].
• Q100593991's language of work or name is recorded as Swedish^[4].
• Q100593991 was published on +1992-10-22T00:00:00Z^[5].
• Q100593991's main subject is medication^[6].
• Q100593991's main subject is Q107157371^[7].
• Q100593991's work available at URL is recorded as https://www.riksdagen.se/sv/dokument-lagar/dokument/_sfs-1992-1025^[8].
• Q100593991's work available at URL is recorded as http://data.riksdagen.se/dokument/sfs-1992-1025^[9].
• Q100593991's applies to jurisdiction is recorded as Sweden^[10].
• Q100593991's legal citation of this text is recorded as SFS 1992:1025^[11].
• Q100593991's published in is recorded as Swedish Code of Statutes 1992^[12].
• Q100593991's title is recorded as Förordning (1992:1025) med bemyndigande för Riksförsäkringsverket att meddela föreskrifter om prisnedsättning för läkemedel i vissa fall^[13].
• Q100593991's repealed by is recorded as Q100591228^[14].
• Q100593991's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q100593991's copyright status is recorded as public domain^[16].
• Q100593991's effective date is recorded as +1993-01-01T00:00:00Z^[17].

Body

Definition and Type

Q100593991's instance of is recorded as implementing regulation^[3].